Why Shares in This AI Infrastructure Stock Crashed Today
Vertiv (NYSE: VRT) shares fell more than 16% after its Q2 results. EPS was $1.52 and adjusted operating profit $738M, above prior guidance, but Q2 sales of $3.274B were at the low end of its range. Management raised full-year 2026 guidance for sales, profit, and free cash flow, citing project execution timing and supply chain dynamics.
How this was made

The 30-second read
Why it matters
The market focused on sales and execution commentary, treating the raised full-year guidance as insufficient to offset near-term revenue timing risk.
Market read
A guidance raise did not prevent a large drawdown because investors prioritized near-term sales execution and project complexity risk.
What to watch
Investors may be underweighting the beat in EPS and adjusted operating profit, and the possibility that large, complex projects are inherently lumpy quarter to quarter.
Background
Vertiv reported Q2 results with EPS and adjusted operating profit above the top end of prior guidance, while sales came in at the low end.
Ticker impact
Vertiv shares fell over 16% after Q2 sales landed at the low end of guidance while management raised full-year sales, profit, and cash flow.
Elevated volatility likely persists as investors reassess the durability of project execution and revenue timing into subsequent quarters.
The article highlights a mismatch: EPS and operating profit beat, but sales were at the low end and management cited multiphase project execution and temporary supply chain dynamics.
Market effects
Reinforces that data-center infrastructure demand can be offset by project execution and supply-chain timing, pressuring AI-infrastructure multiples on sales timing.
No specific regional impact described.
No explicit global macro linkage beyond supply-chain dynamics.
Counterpoint
The guidance raise suggests the revenue timing issues may be temporary, so the selloff could be an overreaction to quarter-specific phasing.
Key entities
- companyVertiv
Data center infrastructure provider whose shares dropped sharply after Q2 sales underwhelmed despite raised full-year guidance.


